AstraZeneca's blockbuster breast cancer drug will be added to China's national reimbursement scheme list, according to an ...
AstraZeneca's Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the oral steroid that ...
AstraZeneca's blockbuster breast cancer drug will be added to China's national reimbursement scheme list, according to an ...
Medpage Today on MSN4d
TRK Inhibitor Active in Treatment-Refractory GlioblastomaUsed in conjunction with the oral sonosensitizing agent 5-ALA, the sonodynamic therapy led to a median OS of 15.7 months in ...
AstraZeneca's (NASDAQ:AZN) blockbuster cancer medication, Enhertu, developed with Japanese pharma giant Daiichi Sankyo (OTCPK ...
Researchers review the safety, efficacy, and considerations for COVID-19 vaccination in multiple sclerosis patients, ...
Projected to be worth over $38 billion in the global healthcare market by 2032, AI simulations have the potential to ...
Qiagen strengthens QIAstat-Dx with new Barcelona site to drive growth in infectious diseases and precision medicine testing: Barcelona, Spain Monday, December 2, 2024, 13:00 Hrs [ ...
Truqap’s positive clinical data comes after it failed a late-stage study in metastatic triple-negative breast cancer. It ...
AstraZeneca (AZN) reported positive results from a Phase 3 study of its drug Truqap in the treatment of a certain type of ...
We recently published a list of 12 Best ADR Stocks To Invest In According to Analysts. In this article, we are going to take ...
The UK seems to have suffered a crisis of perception in recent years, but it should not be written off. The UK stock market still holds a wealth of businesses which are rich in the intellectual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback